Home / Stocks / ABCL

ABCL insider trading

AbCellera Biologics Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
12
Bought · 24 mo
$3.6M
Buys · last 90 days
4 · $1.5M
Most recent buy
2026-08-24

Cluster buy detected

3 insiders bought ABCL within a short window (2026-08-12→2026-08-24), $1.5M in total — cluster score 67/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-24Hayden Michael Rcluster
Director
Bought53,613$10.64$570k
2026-08-18Montalbano John S.cluster
Director
Bought10,000$11.03$110k
2026-08-14Hayden Michael Rcluster
Director
Bought46,387$10.37$481k
2026-08-14Booth Andrewcluster
Chief Financial Officer
Bought37,200$10.32$384k
2026-05-18Montalbano John S.
Director
Bought20,000$4.77$95k
2026-03-02Thermopylae Holdings Ltd.
10% owner
Bought38,000$3.44$131k
2026-02-27Thermopylae Holdings Ltd.
10% owner
Bought177,457$3.27$580k
2026-02-27Booth Andrew
Chief Financial Officer
Bought42,600$3.42$146k
2025-11-26Montalbano John S.
Director
Bought50,000$3.57$178k
2025-03-11Thermopylae Holdings Ltd.
10% owner
Bought343,631$2.16$742k
2025-03-10Montalbano John S.
Director
Bought25,000$2.30$58k
2025-03-07Montalbano John S.
Director
Bought60,000$2.34$140k

Most active insider buyers

InsiderRoleBuysTotal bought
Thermopylae Holdings Ltd.10% owner3$1.5M
Hayden Michael RDirector2$1.1M
Montalbano John S.Director5$582k
Booth AndrewChief Financial Officer2$530k

See ABCL on the chart

Every insider buy and sell for ABCL plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.